Ovarian cancer specific survival in MMR mutation carriers and BRCA mutation carriers
| Survival | MMR (present study) | Brca1/Brca211 |
| All (n=144) | All (n=49) | |
| 5 year | 82.7% | 58.6% |
| 10 year | 80.6% | 36% |
| Stages 1 and 2 (n=110) | Stages 3and 4 (n=25) | Stages 1 and 2 (n=15) | Stages 3 and 4 (n=34) | |
| 5 year | 89% | 59% | 87% | 55% |
| 10 year | 87% | 53% | 87% | 19% |